课题基金 / 基金详情

Hematopoietic Stem Cells for Transplantation

Hematopoietic Stem Cells for Transplantation
用于移植的造血干细胞
批准号:
8213672
负责人:
SAUL Joseph SHARKIS
金额:
$207.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-26 至 2014-01-31

项目摘要

项目成果

SAUL Joseph SHARKIS的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This grant proposal focuses our sustained laboratory and clinical research experience in animal and human stem cell biology and leukemia to extend exciting new investigations on normal tissue-specific and cancer stem cells. The investigators in this PPG look forward to discovering key information about the defining characteristics of cancer stem cells. This knowledge will enable us to develop new methods to better identify and isolate these rare cells for further study. In addition, this PPG seeks increased understanding of the pathophysiologic mechanisms of cancer stem cells, particularly the signaling pathways that these cells depend on for their persistence and other malignant behavior. This basic information will suggest new clinical cancer stem cell targets, which we will proceed to attack via pharmacologic and biologic approaches. Both within the Projects and in interactions among the Projects and Cores, clinical research and laboratory inquiries will proceed in parallel, so that insights generated in one sphere will translate to, and promote progress in the other. We believe that our highly interactive, closely integrated, translational approach is the best way to determine mechanisms of normal and malignant stem cell biology, and simultaneously to develop new treatments utilizing normal stem cells and targeting malignant stem cells in human diseases. Relevance: There is growing evidence suggesting that many cancers originate in early (stem or progenitor) cells and that the mature cancers continue to be maintained by a stem-progenitor cell hierarchy. Our group has provided important evidence demonstrating the existence of discrete populations of cancer stem cells in human diseases, and our results support the prediction that cancer recurrence in patients after chemotherapy may be due to failure to eradicate the rare, sustaining cancer stem cell population, despite massive reduction of the predominant bulk population of mature cancer cells. The investigators in this PPG look forward to discovering key information about the defining characteristics and molecular mechanisms of cancer stem cells that will provide new ways to identify and attack cancer stem cells therapeutically.
期刊论文(59)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1053/j.seminhematol.2008.07.007
发表时间: 2008-07
期刊: Seminars in hematology
影响因子: 3.6
作者: [Small D]
通讯作者: Small D
DOI: 10.1111/bjh.13164
发表时间: 2015-02
期刊: British journal of haematology
影响因子: 6.5
作者: [Kim M, Tan YS, Cheng WC, Kingsbury TJ, Heimfeld S, Civin CI]
通讯作者: Civin CI
DOI: 10.1016/j.ygyno.2016.03.022
发表时间: 2016-08
期刊: Gynecologic oncology
影响因子: 4.7
作者: [Sharrow AC, Perkins B, Collector MI, Yu W, Simons BW, Jones RJ]
通讯作者: Jones RJ
DOI: 10.1097/cji.0b013e31820d2a21
发表时间: 2011-03
期刊: Journal of immunotherapy (Hagerstown, Md. : 1997)
影响因子: --
作者: [Zhang H, Cui Y, Voong N, Sabatino M, Stroncek DF, Morisot S, Civin CI, Wayne AS, Levine BL, Mackall CL]
通讯作者: Mackall CL
25
    Mouse Transplantation
    • 批准号:
      8212938
    • 项目类别:
    • 资助金额:
      $24.1万
    • 财政年份:
      2011
    • 负责人:
      SAUL Joseph SHARKIS
    • 依托单位:
    Identification of Tissue Specific Stem Cells
    • 批准号:
      8212936
    • 项目类别:
    • 资助金额:
      $30.3万
    • 财政年份:
      2011
    • 负责人:
      SAUL Joseph SHARKIS
    • 依托单位:
    Mechanisms Underlying Stem Cell Plasticity
    • 批准号:
      7891076
    • 项目类别:
    • 资助金额:
      $9.77万
    • 财政年份:
      2009
    • 负责人:
      SAUL Joseph SHARKIS
    • 依托单位:
    Identification of Tissue Specific Stem Cells
    • 批准号:
      7355830
    • 项目类别:
    • 资助金额:
      $32.46万
    • 财政年份:
      2008
    • 负责人:
      SAUL Joseph SHARKIS
    • 依托单位: